186 related articles for article (PubMed ID: 17928431)
1. Use of synthetic derivatives to determine the minimal active structure of cytokine-inducing lipoteichoic acid.
Deininger S; Figueroa-Perez I; Sigel S; Stadelmaier A; Schmidt RR; Hartung T; von Aulock S
Clin Vaccine Immunol; 2007 Dec; 14(12):1629-33. PubMed ID: 17928431
[TBL] [Abstract][Full Text] [Related]
2. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release.
Morath S; Stadelmaier A; Geyer A; Schmidt RR; Hartung T
J Exp Med; 2002 Jun; 195(12):1635-40. PubMed ID: 12070290
[TBL] [Abstract][Full Text] [Related]
3. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives.
Deininger S; Stadelmaier A; von Aulock S; Morath S; Schmidt RR; Hartung T
J Immunol; 2003 Apr; 170(8):4134-8. PubMed ID: 12682244
[TBL] [Abstract][Full Text] [Related]
4. Role of lipoteichoic acid in the phagocyte response to group B streptococcus.
Henneke P; Morath S; Uematsu S; Weichert S; Pfitzenmaier M; Takeuchi O; Müller A; Poyart C; Akira S; Berner R; Teti G; Geyer A; Hartung T; Trieu-Cuot P; Kasper DL; Golenbock DT
J Immunol; 2005 May; 174(10):6449-55. PubMed ID: 15879147
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
6. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids.
Ryu YH; Baik JE; Yang JS; Kang SS; Im J; Yun CH; Kim DW; Lee K; Chung DK; Ju HR; Han SH
Int Immunopharmacol; 2009 Jan; 9(1):127-33. PubMed ID: 19013542
[TBL] [Abstract][Full Text] [Related]
7. Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-[alpha] in mediating LTA-induced interleukin-8 generation.
Hattar K; Grandel U; Moeller A; Fink L; Iglhaut J; Hartung T; Morath S; Seeger W; Grimminger F; Sibelius U
Crit Care Med; 2006 Mar; 34(3):835-41. PubMed ID: 16521278
[TBL] [Abstract][Full Text] [Related]
8. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG.
Claes IJ; Segers ME; Verhoeven TL; Dusselier M; Sels BF; De Keersmaecker SC; Vanderleyden J; Lebeer S
Microb Cell Fact; 2012 Dec; 11():161. PubMed ID: 23241240
[TBL] [Abstract][Full Text] [Related]
9. Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists.
Draing C; Traub S; Deininger S; Mang P; Möller HM; Manso M; Rossi F; Morath S; Hartung T; von Aulock S
Eur J Immunol; 2008 Mar; 38(3):797-808. PubMed ID: 18266269
[TBL] [Abstract][Full Text] [Related]
10. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages.
Hong SW; Baik JE; Kang SS; Yun CH; Seo DG; Han SH
Mol Immunol; 2014 Feb; 57(2):284-91. PubMed ID: 24216318
[TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance.
Schmidt RR; Pedersen CM; Qiao Y; Zähringer U
Org Biomol Chem; 2011 Apr; 9(7):2040-52. PubMed ID: 21327200
[TBL] [Abstract][Full Text] [Related]
12. A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues.
Stadelmaier A; Figueroa-Perez I; Deininger S; von Aulock S; Hartung T; Schmidt RR
Bioorg Med Chem; 2006 Sep; 14(18):6239-54. PubMed ID: 16782351
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.
Han SH; Kim JH; Martin M; Michalek SM; Nahm MH
Infect Immun; 2003 Oct; 71(10):5541-8. PubMed ID: 14500472
[TBL] [Abstract][Full Text] [Related]
14. Structure/function relationships of lipoteichoic acids.
Morath S; von Aulock S; Hartung T
J Endotoxin Res; 2005; 11(6):348-56. PubMed ID: 16303090
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.
Warshakoon HJ; Burns MR; David SA
Antimicrob Agents Chemother; 2009 Jan; 53(1):57-62. PubMed ID: 18955537
[TBL] [Abstract][Full Text] [Related]
16. Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity.
Rockel C; Hartung T; Hermann C
Immunobiology; 2011 Mar; 216(3):316-21. PubMed ID: 20965605
[TBL] [Abstract][Full Text] [Related]
17. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae.
Draing C; Pfitzenmaier M; Zummo S; Mancuso G; Geyer A; Hartung T; von Aulock S
J Biol Chem; 2006 Nov; 281(45):33849-59. PubMed ID: 16943191
[TBL] [Abstract][Full Text] [Related]
18. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans.
Hoogerwerf JJ; de Vos AF; Bresser P; van der Zee JS; Pater JM; de Boer A; Tanck M; Lundell DL; Her-Jenh C; Draing C; von Aulock S; van der Poll T
Am J Respir Crit Care Med; 2008 Jul; 178(1):34-41. PubMed ID: 18403723
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-inducing lipoteichoic acids of the allergy-protective bacterium Lactococcus lactis G121 do not activate via Toll-like receptor 2.
Fischer K; Stein K; Ulmer AJ; Lindner B; Heine H; Holst O
Glycobiology; 2011 Dec; 21(12):1588-95. PubMed ID: 21666273
[TBL] [Abstract][Full Text] [Related]
20. Distinct pattern of immune tolerance in dendritic cells treated with lipopolysaccharide or lipoteichoic acid.
Yoon HS; Kim G; Ju YJ; Cheon IS; Hong SW; Kim DW; Park BC; Han SH; Yun CH
Mol Immunol; 2017 Nov; 91():57-64. PubMed ID: 28886587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
